Aditya Birla Capital Limited will host an analyst and investor conference call on July 31, 2026, to discuss its financial results for the quarter ended June 30, 2026. The meeting is scheduled to begin at 16:30 IST and will include a performance update followed by a question-and-answer session. This initiative is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015.

The press release and investor presentation will be available on the company's website following the result announcement on the same day. Santosh Haldankar, Company Secretary & Compliance Officer, signed the intimation on July 21, 2026.

Conference Call Details

Participants can join the discussion using the following dial-in numbers:

The company has advised participants to pre-register to avoid wait time. An audio recording and transcript of the conference call will be uploaded to the company's website in due course.

Aditya Birla Capital has invested ₹123.89 crore in its associate, Aditya Birla Health Insurance Co. Limited, through a rights issue of equity shares. The transaction was completed on 21 July 2026 to meet the solvency margin requirements of the health insurance subsidiary. This investment was made on a rights basis for an aggregate cash consideration of ₹123,89,43,300, with the shares allotted on the same date.

Transaction Details

The investment is classified as a related party transaction since Aditya Birla Health Insurance is an associate of the company. The deal was conducted at arm's length. Following the allotment, the percentage shareholding of Aditya Birla Capital in Aditya Birla Health Insurance remains unchanged at 45.89%.

Strategic Context

The capital infusion is directed towards meeting the solvency margin of Aditya Birla Health Insurance. The health insurance entity operates within the same industry vertical and is an existing associate of the parent company. No governmental or regulatory approvals were required for this specific acquisition of shares.